Chapter 33. Malaria: A Third World Disease in Need of First World Drug Development

Annual Reports in Medicinal Chemistry

Volumn 34, Issue C, 1999, Pages 349-358

  Wirth, Dyann F ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001803584     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(08)60595-3     Document Type: Article

References (23)

1. World Health Report 1999. 1999, World Health Organization: Geneva, Switzerland
2. Trouiller P. Drug Development Output form 1075-1996: What Proportion for Tropical Diseases. Int J Infect Dis 3 (1998) 61-63
3. Olliaro P., Cattani J., and Wirth D. Malaria, the submerged disease. JAMA 275 3 (1996) 230-233
4. Bustos D., et al. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for trreatment of acute Plasmodium falciaprum malaria in the Philippines. J Infect Dis 179 (1999) 1587-1590
5. de Alencar F., et al. Atovaquone and proguanil for treatment of malaria in Brazil. J Infect Dis 175 (1997) 1544-1547
6. de Alencar F., et al. The biology of malaria parasites (1987), World Health Organization, Geneva, Switzerland
7. Nussenzweig R., and Long C. Malaria vaccines: multiple targets. Science 265 (1994) 1381-1383
8. Olliaro P., and Yuthavong Y. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol Ther 81 (1999) 91-110
9. Amboise-Thomas P. The rational use of quinghaosu and its derivatives in the treatment of malaria in 1998. Med Trop (Mars) 58 (1998) 6-8
10. Francis S., Sullivan D., and Goldberg D. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51 (1997) 97-123
11. Slater A. Chloroquine: mecanism of drug action and resistance in Plasmodium falciparum. Pharmacol Ther 57 (1993) 203-235
12. Baruch D., et al. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythroctyre receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 93 (1996) 3497-3502
13. Miller L., and Hoffman S. Research toward vaccines against malaria. Nat Med 4 (1998) 520-524
14. White N. Quinghasou in combinations. Med Trop Mars 58 (1998) 85-88
15. Newton P., and Whtie N. Malaria: new developments in treatment and prevention. Annu Rev Med 50 (1999) 179-192
16. Gottesman M. Selection and maintenance of multidrug-resistant cells. Methods Enzymol 292 (1998) 248-258
17. Martin S., Oduola A., and Milhous W. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235 (1987) 899-901
18. Wilson C., et al. Amplification of pfmdr1 associated with mefloquine and halofantrine resistnace in Plasmodium falciparum from Thailand. Mol Biochemo Parasitol 57 (1993) 151-160
19. Su X., et al. Complex polymorphsims in an approximately 300 kDA protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91 (1997) 593-603
20. Stoute J., et al. Long term efficacy and immune responses following immunization with the RTS, S malaria vaccine. J Infect Dis 178 (1998) 1139-1144
21. Lengler C., et al. Relative versis absolute risk of dying reduction after using insecticide-treated nets for malaria control in Africa. Trop Med Int Health 3 (1998) 286-290
22. Wirth D. Malaria: a 21st century solution for an ancient disease. Nat Med 4 (1998) 1360-1362
23. Gardner M., et al. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science 282 (1998) 1126-1132